Skip to product information
1 of 1

Abbott Rapid Dx North America LLC Drugs of Abuse Test Kit T-Cup® AMP1000, BAR300, BZO300, BUP10, COC300, mAMP/MET1000, MDMA500, MTD300, MOP(OPI300), OXY100, PCP25, PPX300, TCA1000, THC50 (CR, pH, SG) 25 Tests CLIA Waived - Box of 25 - TDOA-1145A3-BX

Abbott Rapid Dx North America LLC Drugs of Abuse Test Kit T-Cup® AMP1000, BAR300, BZO300, BUP10, COC300, mAMP/MET1000, MDMA500, MTD300, MOP(OPI300), OXY100, PCP25, PPX300, TCA1000, THC50 (CR, pH, SG) 25 Tests CLIA Waived - Box of 25 - TDOA-1145A3-BX

Regular price $235.99
Sale price $235.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Abbott Rapid Dx North America LLC Drugs of Abuse Test Kit T-Cup® AMP1000, BAR300, BZO300, BUP10, ...

Item Id 1155201
MF Id# TDOA-1145A3
Brand T-Cup®
Manufacturer Abbott Rapid Dx North America LLC
Country of Origin Unknown
Application Drugs of Abuse Test Kit
CLIA Classification CLIA Waived
CLIA Classified CLIA Waived
Contents 1 (25) Test Devices Individually Pouched, Instructions for use
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued Y
Is_Medical_Device Y
Lot_Tracking_Flag N
Number of Tests 25 Tests
On_Allocation N
Purchase Program Type Standard Purchase
Reading Type Visual Read
Sample Type Urine Sample
Specialty Toxicology
Supplier_ID 64711003
Test Format Test Cup Format
Test Kit Type Rapid
Test Method Lateral Flow Method
Test Name AMP1000, BAR300, BZO300, BUP10, COC300, mAMP/MET1000, MDMA500, MTD300, MOP(OPI300), OXY100, PCP25, PPX300, TCA1000, THC50 (CR, pH, SG)
Test Type 14-Drug Panel with Adulterants
Time to Results 5 Minute Results
UNSPSC Code 41116146

Features

  • The Multi-Drug Urine Test Cup is a competitive binding, lateral flow immunochromatographic assay
  • 12-18 month expiration date on all drug test kits (guaranteed)
  • FDA-approved, CLIA Waived
  • Fast results in 5 minutes
About your query!
Recently Viewed